Cost-Effectiveness of Remote Symptom Monitoring During Adjuvant Endocrine Therapy in Breast Cancer
- DOI
- 10.1001/jamanetworkopen.2026.41402
- Published
- 2026-11-02
- Container
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1001/jamanetworkopen.2026.41402,
title = {Cost-Effectiveness of Remote Symptom Monitoring During Adjuvant Endocrine Therapy in Breast Cancer},
author = {Xin Hu and Freddie Yang and Andrea N. Curry and Gregory A. Vidal and Teresa M. Waters and Chad Robichaux and Lee S. Schwartzberg and Ilana Graetz},
year = {2026},
journal = {JAMA Network Open},
doi = {10.1001/jamanetworkopen.2026.41402},
url = {https://doi.org/10.1001/jamanetworkopen.2026.41402}
}RIS
TY - JOUR TI - Cost-Effectiveness of Remote Symptom Monitoring During Adjuvant Endocrine Therapy in Breast Cancer AU - Xin Hu AU - Freddie Yang AU - Andrea N. Curry AU - Gregory A. Vidal AU - Teresa M. Waters AU - Chad Robichaux AU - Lee S. Schwartzberg AU - Ilana Graetz PY - 2026 JO - JAMA Network Open DO - 10.1001/jamanetworkopen.2026.41402 UR - https://doi.org/10.1001/jamanetworkopen.2026.41402 ER -
APA
Hu, X., Yang, F., Curry, A. N., Vidal, G. A., Waters, T. M., Robichaux, C., Schwartzberg, L. S., & Graetz, I. (2026). Cost-Effectiveness of Remote Symptom Monitoring During Adjuvant Endocrine Therapy in Breast Cancer. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2026.41402
Source records
- crossref · retrieved 2026-11-04T10:44:58.634Z